Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Ex-Novartis exec joins Ipsen as President, Head of Specialty Care

February 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen

Harout Semerjian has joined French pharma firm Ipsen as President, Head of Specialty Care International Region & Global Franchises, the …
Appointment

Ipsen names new Head of Global Medical Affairs

February 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen

French pharmaceutical firm Ipsen has announced its recruitment of Dr Sotirios Stergiopoulos as its Senior Vice President and Head of …
Appointment

Chan Zuckerberg Biohub kick-starts hiring with 47 recruits

February 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CZ Biohub, Mark Zuckerberg, Zuckerberg

The Chan Zuckerberg Biohub, otherwise known as CZ Biohub, has announced its first in-take of recruits. The appointments are predominantly …
Appointment

More troubles for Teva as Israeli authorities open bribery investigation

February 8, 2017 Research and Development, Sales and Marketing Teva, bribery

Teva continues to struggle this week; after being hit with the bombshell that CEO Erez Vigodman, its third chief executive …
News

Alexion hits out at NICE ruling on Strensiq

February 8, 2017 Research and Development, Sales and Marketing Alexion, NICE, Strensiq

NICE has again drawn the ire of a company over its recommendation of its drug, this time round it’s Alexion …
News

Mylan pays $96.5 million to settle pay-for-delay case

February 7, 2017 Research and Development, Sales and Marketing Cephalon, Mylan, Teva, antitrust

Mylan has agreed to pay $96.5 million in order to settle an antitrust case. The case was related to the …
News

New EPO regulations bad for biotech innovation, experts claim

February 7, 2017 Manufacturing and Production, Sales and Marketing EPO, IFPMA, SMEs, biotech

A recently-adopted initiative by the European Patent Office (EPO) to reduce patient examination times could lead to a stagnation of …
News

MSD aims to get the jump on BMS treating bladder cancer

February 6, 2017 Manufacturing and Production, Sales and Marketing BMS, Bristol-Myers Squibb, MSD, keytruda, opdivo

Bristol-Myers Squibb’s Opdivo was only just approved for second-line treatment of bladder cancer, but MSD has attempted to have its …
News

Sanofi reinforces senior staff with two new execs

February 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi

Sanofi has reinforced its senior staff with a double-whammy of appointments; firstly, the French firm has announced that it is …
Appointment

Medherant appoints new Chairman

February 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medherant

Medherant has brought in Dr Ken Cunningham as Chair in a bid to strengthen the company as it moves into …
Appointment

J&J breast implants “may have harmed thousands”, claims fresh lawsuit

February 6, 2017 Sales and Marketing J&J, JJ, Mentor Worldwide, breast implants

Mentor Worldwide, a unit of US pharma firm Johnson & Johnson, has been accused of selling defective breast implants and …
News

FDA clears Opdivo to treat most common form of bladder cancer

February 6, 2017 Sales and Marketing BMS, Bristol-Myers Squibb, MSD, bladder cancer, immunotherapy, keytruda, opdivo

Bristol-Myers Squibb’s Opdivo has acquired another indication – being given the go-ahead for treatment of patients with metastatic urothelial carcinoma. …
News

Socially vigilant: Does pharmacovigilance need secondary data & social media?

February 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, MHRA, pharmacovigilance

As the world’s drug consumption continues to rise alongside advancements in the medical and pharmaceutical industries, so too do new …
Feature

Link discovered between immune system genes and leukaemia

February 6, 2017 Research and Development, Sales and Marketing Bloodwise, ICR, leukaemia

Research coming out of The Institute of Cancer Research, and funded by charity Bloodwise, has found that people who inherit …
News

Phase 2 failure for Innate Pharma leukaemia drug

February 6, 2017 Research and Development, Sales and Marketing Innate Pharma, leukaemia, lirilumab

Lirilumab, Innate Pharma’s acute myeloid leukaemia (AML) treatment, has failed to meet its primary end point in a recent Phase …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026